APA (7th ed.) Citation

Rathke, H., Holland-Letz, T., Mier, W., Flechsig, P., Mavriopoulou, E., Röhrich, M., . . . Kratochwil, C. (2020). Response prediction of 177Lu-PSMA-617 radioligand therapy using prostate-specific antigen, chromogranin A, and lactate dehydrogenase. Journal of nuclear medicine, 61(5), . https://doi.org/10.2967/jnumed.119.231431

Chicago Style (17th ed.) Citation

Rathke, Hendrik, et al. "Response Prediction of 177Lu-PSMA-617 Radioligand Therapy Using Prostate-specific Antigen, Chromogranin A, and Lactate Dehydrogenase." Journal of Nuclear Medicine 61, no. 5 (2020). https://doi.org/10.2967/jnumed.119.231431.

MLA (9th ed.) Citation

Rathke, Hendrik, et al. "Response Prediction of 177Lu-PSMA-617 Radioligand Therapy Using Prostate-specific Antigen, Chromogranin A, and Lactate Dehydrogenase." Journal of Nuclear Medicine, vol. 61, no. 5, 2020, https://doi.org/10.2967/jnumed.119.231431.